Deprivation Still Costs Lives: Socioeconomic Inequalities in Melanoma Care and Outcomes in England
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Melanoma incidence continues to rise in England, but inequities in cancer outcomes persist despite universal healthcare. Socioeconomic deprivation has been linked to poorer outcomes across several cancer types, yet comprehensive national data on its impact in melanoma are limited. OBJECTIVES: To examine the influence of socioeconomic status upon malignant melanoma incidence, stage at diagnosis, treatment and outcomes in England. METHODS: This population-based cohort study included 68,869 patients diagnosed with malignant melanoma in England between 2016 and 2020, identified from the National Disease Registration Service and linked to Hospital Episode Statistics, mortality data and the Systemic Anti-Cancer Therapy (SACT) dataset. Logistic regression examined associations between deprivation (Index of Multiple Deprivation quintiles) and stage at presentation, treatment received and mortality, adjusting for demographic and clinical covariates. RESULTS: Compared with patients in the least deprived quintile, those in the most deprived quintile were diagnosed at a younger median age (62 vs 67 years) and more often with stage 4b disease (10% vs 8%). After adjustment, patients in the least deprived quintile were more likely than those in the most deprived quintile to receive systemic therapies (aOR 1.13, 95% CI 1.02-1.25, p = 0.02) and less likely to die from any cause within one year (aOR 0.71, 95% CI 0.62-0.82, p < 0.001). CONCLUSIONS: In England, living in a more deprived area is modestly associated with more advanced melanoma at diagnosis, lower receipt of systemic therapy and higher one-year mortality. Melanoma awareness, early detection and access to systemic therapy should be targeted towards patients living in the most deprived areas.
Source: British Journal of Dermatology
DOI: 10.1093/bjd/ljag500
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,920
OpenAlex ID: W7236571397
